# FDA Inspection 1191165 - AbbVie Inc. - October 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/abbvie-inc/86c738e7-4002-4274-a0ef-a090a661ea43
Source feed: FDA_Inspections

> FDA Inspection 1191165 for AbbVie Inc. on October 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191165
- Company Name: AbbVie Inc.
- Inspection Date: 2022-10-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277010 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d998b409-04ec-4d4c-8b31-fbb0807bde69)
- [FDA Inspection 1277010 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/20aba2c4-bf11-4f96-ab4a-2bff02a0efb6)
- [FDA Inspection 1257605 - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/48e53750-1fe1-4280-8d26-fdff5c926853)
- [FDA Inspection 1257605 - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d600c417-90fe-4fef-ae17-05d2b6b5bb8b)
- [FDA Inspection 1230795 - 2025-02-18](https://www.keypedia.com/records/fda_inspections/abbvie-inc/67c3b515-c0ea-487d-a385-558dd66f3031)

Company: https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c